Navigation Links
2013 Pharmaceutical Drug Naming Trends
Date:5/2/2013

NEW YORK, May 2, 2013 /PRNewswire-iReach/ -- For the first quarter of the 2013 calendar year, the FDA's Center for Drug Evaluation and Research (CDER) has approved nine new molecular entities. A total of 39 novel new medicines were approved in 2012, the highest total in sixteen years. Our conclusions are based on a comparison of the average number of letters and syllables in tandem with POCA (Phonological Orthographic Computer Analysis) for the combined proprietary drug names approved in 2012 and 2013. Two of the approved NME's in 2012, choline C-11 and raxibacumab, were approved with the non-proprietary name in place of a proprietary name. The average for both number of letters and number of syllables has increased in the first quarter of 2013. The average number of letters increased from 7.2 to 7.7. The average number of syllables increased from 2.9 to 3.2.

(Photo: http://photos.prnewswire.com/prnh/20130502/CG05717)

The comparison of POCA ratings includes a merged (M) average of the distinct orthographic (O) and phonetic (P) ALINE algorithms as well as the individual similarity ratings derived from all drug products listed within the Orange Book (as of April 16th, 2013). Although the average percentage of similarity for the most similar names remained consistent at 62% (merged) and 63% (orthographic) from 2012 to 2013, the phonetic average for the most similar names increased in 2013. For 2013 Q1 approvals, we note that the number of names where similarity is greater or equal to 60% is in decline based on the merged and orthographic similarity measures.

While it remains early in the calendar year of 2013, the trend to create names which can establish points of difference related to the number and type of letters, i.e., ascending and descending letter characteristics, is logical in the context of known FDA Division of Medication Error Pr
'/>"/>

SOURCE Brandpersand
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SynteractHCR Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in US and Europe
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
3. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
4. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
5. Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics.
7. Paratek Pharmaceuticals Announces Expanded FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline
8. GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market
9. Acsis Introduces "Serialization in a Box," Enabling Pharmaceutical Companies to Achieve E-Pedigree Compliance
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds ... its store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ... upgrade and policy support, China,s ... years, with total market size rising from 3.28 billion ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... , SILVER SPRING, Md., Nov. 13 The U.S. ... acid), the first non-hormonal product cleared to treat heavy ... that helps blood to clot. , (Logo: ... is reported each year by about 3 million U.S. ...
... FRANCISCO, Nov. 13 Quantros, a leading software ... that it has partnered with Det Norske Veritas ... by the Centers for Medicare and Medicaid Services ... now integrate that company,s accreditation standards into the ...
Cached Medicine Technology:FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 2Quantros Announces Partnership With Hospital Accreditation Agency DNV 2
(Date:4/24/2014)... Pa. (April 24, 2014) - Contact lenses coated with an ... lens-related infections, reports a study in Optometry and ... Academy of Optometry . The journal is published by ... Wolters Kluwer Health . , Studies in animals and now ... the antimicrobial peptide melimine, according to the new research by ...
(Date:4/24/2014)... Fibroblasts, cells long thought to be boring and irrelevant, ... with heart disease. , Researcher Dr Milena Furtado, and ... at Monash University, found the heart cell fibroblast is ... for a healthy beating heart. , In research published ... found that cardiac fibroblasts are unique cells due to ...
(Date:4/24/2014)... first in the world to discover a gene mutation ... , Ameloblastoma is an odontogenic tumour with a high ... found in the posterior of the lower jaw. Ameoloblastomas ... in the jaws as well as loss of several ... for surgery and the recurrence of ameloblastoma, but finding ...
(Date:4/24/2014)... research led by a scientist at the University of ... element in the development of the nervous system may ... breast cancer., A research team, led by Dr ... Department of Biology at York, has studied how voltage-gated ... These channels are found in the membranes of excitable ...
(Date:4/23/2014)... State University Spokane have developed a new way ... off behind the wheel. , Their recently patented ... more variable in drowsy driversand offers an affordable ... driver drowsiness detection systems. , Van Dongen"Video-based systems ... is drifting out of its lane are cumbersome ...
Breaking Medicine News(10 mins):Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Boring cells could hold the key to heart disease 2Health News:Breast cancer replicates brain development process 2Health News:WSU innovation improves drowsy driver detection 2
... , BUENOS AIRES, Argentina, Sept. 1 Frost ... its 2009 Customer Value Leadership Award in the Latin American ... to continuously add value to new and existing healthcare providers, ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...
... , , , ... Cell Biosciences, Inc. today launched a service program ... and biotechnology companies. Under the Cell Biosciences Focus Assay ... cell signaling proteins in their specimens. This information provides ...
... BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. ... China-based medical device,company that develops, manufactures and markets advanced ... the fourth,fiscal quarter ("4Q FY2008") and the full fiscal ... 4Q FY2008 Highlights, -- Revenues ...
... Barcelona, Spain, 1 September: Primary angioplasty (with stent ... infarction (AMI), but it is not available to many ... (ie, catheterisation laboratories) for its wider use. The Stents ... the use of primary angioplasty in the treatment of ...
... ... the latest optical aids, such as the Optelec FarView, and providing important eye health tips ... ... students and teachers throughout the country are gearing up for back-to-school season. Optelec ...
... PAINWeek ... meeting provides knowledge and tools for frontline practitioners who treat patients in pain. The conference ... 2009 and offers over 100 CE/CME hours during the 4-day conference. , ... Montclair, NJ (PRWEB) September 1, 2009 -- ...
Cached Medicine News:Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4Health News:Cell Biosciences Launches Unique Protein Phosphorylation Assay Service 2Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 2Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 3Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 4Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 5Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 6Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 7Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 8Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 9Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 10Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 11Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 12Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 13Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 14Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 15Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 16Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 17Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 18Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 19Health News:China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results 20Health News:Stent for life initiative 2Health News:Optelec Offers Back-to-School Low Vision Tech & Eye Health Tips 2Health News:Optelec Offers Back-to-School Low Vision Tech & Eye Health Tips 3Health News:PAINWeek 2009 Welcomes Over 1,000 Attendees 2Health News:PAINWeek 2009 Welcomes Over 1,000 Attendees 3
... part of the AXIOM family, which ... the clinical angiography, card- angiography, and ... functional and business pages you can ... delivers unrivalled value to users and ...
Spring Type with lock. Titanium....
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
... The STARFlex is a fourth generation ... CardioSEAL by the addition of a unique ... coil micro-spring. The micro-spring is attached to ... and provides a self-adjusting positioning mechanism which ...
Medicine Products: